Compare KVUE & WTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KVUE | WTW |
|---|---|---|
| Founded | 2022 | 1828 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Specialty Insurers |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.1B | 27.4B |
| IPO Year | 2023 | N/A |
| Metric | KVUE | WTW |
|---|---|---|
| Price | $18.51 | $293.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | $19.58 | ★ $374.57 |
| AVG Volume (30 Days) | ★ 62.2M | 1.1M |
| Earning Date | 02-17-2026 | 02-03-2026 |
| Dividend Yield | ★ 4.44% | 1.28% |
| EPS Growth | ★ 35.31 | N/A |
| EPS | 0.75 | ★ 16.26 |
| Revenue | ★ $15,006,000,000.00 | $9,708,000,000.00 |
| Revenue This Year | N/A | $9.45 |
| Revenue Next Year | $2.72 | $6.02 |
| P/E Ratio | $25.01 | ★ $17.70 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $14.02 | $275.60 |
| 52 Week High | $25.17 | $352.79 |
| Indicator | KVUE | WTW |
|---|---|---|
| Relative Strength Index (RSI) | 66.60 | 39.06 |
| Support Level | $17.96 | $275.60 |
| Resistance Level | $18.97 | $344.99 |
| Average True Range (ATR) | 0.37 | 12.14 |
| MACD | 0.08 | -3.47 |
| Stochastic Oscillator | 72.57 | 27.31 |
Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.
Willis Towers Watson PLC is an advisory, broking, and solutions company that provides data-driven, insight-led solutions in the areas of people, risk, and capital. The company's segments include Health, Wealth & Career (HWC) and Risk & Broking (R&B). The HWC segment provides an array of advice, broking, solutions and technology for employee benefit plans, institutional investors, compensation and career programs, and employee experience overall. It focuses on four key areas: Health, Wealth, Career and Benefits Delivery & Outsourcing. The R&B segment provides risk advice, insurance brokerage and consulting services to clients ranging from small businesses to multinational corporations. Its R&B segment includes two businesses: Corporate Risk & Broking and Insurance Consulting and Technology.